Literature DB >> 3108140

Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro.

A Ueki, T Sai, H Oka, M Tabata, K Hosokawa, Y Mochizuki.   

Abstract

The third component of complement (C3) is synthesized and released by cultured human capillary endothelial cells. After the incubation of cells in a methionine-free medium containing 35S-methionine for 48 hr, culture supernatants were immunoprecipitated with anti-human C3 serum. SDS solubilization and 2-ME reduction of the immunoprecipitates, followed by separation with SDS-polyacrylamide gel electrophoresis and autoradiography, revealed two major bands comparable to those of the alpha and beta chains of human C3. The content of C3 in the culture medium harvested at different time-intervals was determined by ELISA. The C3 secretion rate was about 250 ng/10(6) cells/5 days in the primary culture medium and 75 ng/10(6) cells/5 days after seven passages. The capillary endothelial cells described here have factor VIIIRAg specific for endothelial cells, and exhibit ring formation resembling capillary lumina, but they lack Weibel-Palade bodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108140      PMCID: PMC1453310     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium.

Authors:  M A Gimbrone; R W Alexander
Journal:  Science       Date:  1975-07-18       Impact factor: 47.728

2.  Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4).

Authors:  R E Hall; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

3.  Endothelial cells and the biology of factor VIII.

Authors:  E A Jaffe
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

4.  C3 polymorphism: genetic linkage relations.

Authors:  T Gedde-Dahl; P Teisberg; E Thorsby
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Characterization of the collagen synthesized by endothelial cells in culture.

Authors:  B V Howard; E J Macarak; D Gunson; N A Kefalides
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

9.  Third component of complement (C3): structural properties in relation to functions.

Authors:  V A Bokisch; M P Dierich; H J Mūller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.

Authors:  S M Fu; H G Kunkel; H P Brusman; F H Allen; M Fotino
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  10 in total

1.  Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

Authors:  H Tsukamoto; A Ueda; K Nagasawa; Y Tada; Y Niho
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.

Authors:  H Langeggen; M Pausa; E Johnson; C Casarsa; F Tedesco
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  Complement C3 gene expression and regulation in human glomerular epithelial cells.

Authors:  S H Sacks; W Zhou; A Pani; R D Campbell; J Martin
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

4.  Synthesis of the third component of complement (C3) by human gastric cancer-derived cell lines.

Authors:  E Kitano; H Kitamura
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

5.  Effect of interferon-gamma on complement gene expression in different cell types.

Authors:  D F Lappin; D Guc; A Hill; T McShane; K Whaley
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

6.  Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.

Authors:  R A Brooimans; A P Stegmann; W T van Dorp; A A van der Ark; F J van der Woude; L A van Es; M R Daha
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

7.  Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a.

Authors:  M Coulpier; S Andreev; C Lemercier; H Dauchel; O Lees; M Fontaine; J Ripoche
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

8.  Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis.

Authors:  Junpei Kimura; Osamu Ichii; Saori Otsuka; Tomonori Kanazawa; Yuka Namiki; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

9.  Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein.

Authors:  Eli Magen; Joseph Mishal; Jana Paskin; Zahava Glick; Chaim Yosefy; Mona Kidon; Menachem Schlesinger
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-09       Impact factor: 3.738

10.  Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture.

Authors:  J Ripoche; J A Mitchell; A Erdei; C Madin; B Moffatt; T Mokoena; S Gordon; R B Sim
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.